Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Natera's Beginning Cash Position for the quarter that ended in Mar. 2026 was MXN19,406 Mil.
Natera's quarterly Beginning Cash Position
increased
from Sep. 2025 (MXN18,345 Mil) to Dec. 2025 (MXN18,752 Mil) and
increased
from Dec. 2025 (MXN18,752 Mil) to Mar. 2026 (MXN19,406 Mil).
Natera's annual Beginning Cash Position
increased
from Dec. 2023 (MXN7,912 Mil) to Dec. 2024 (MXN13,391 Mil) and
increased
from Dec. 2024 (MXN13,391 Mil) to Dec. 2025 (MXN17,026 Mil).
Natera Beginning Cash Position Related Terms
Natera Beginning Cash Position Historical Data
* Premium members only.
The historical data trend for Natera's Beginning Cash Position can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Beginning Cash Position of MXN19,406 Mil mean?
Natera (MEX:NTRA) has a Beginning Cash Position of MXN19,406 Mil as of Mar. 2026. Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement. View historical data on Natera and its competitors.
Is Natera's Beginning Cash Position too high?
Natera's current Beginning Cash Position is MXN19,406 Mil. Overall, Natera has a GF Score™ of 60/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Natera's Beginning Cash Position compare to WAT and A?
Natera's Beginning Cash Position of MXN19,406 Mil can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beginning Cash Position for a Medical Diagnostics & Research company?
A good Beginning Cash Position depends on the Medical Diagnostics & Research industry context. However, Beginning Cash Position should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beginning Cash Position mean?
A high Beginning Cash Position can signal that a stock is expensive relative to its fundamentals. Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement. View historical data on Natera and its competitors. Natera's current Beginning Cash Position is MXN19,406 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Natera stock overvalued right now?
Based on GuruFocus' analysis, Natera (MEX:NTRA) is currently considered Modestly Overvalued. The stock's GF Value™ is MXN3,587.26, compared to a current price of MXN4,600.00 — trading 28.2% above its estimated fair value. The current Beginning Cash Position is MXN19,406 Mil. Natera's overall GF Score™ is 60/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beginning Cash Position calculated?
Beginning Cash Position is calculated from a company's financial statements. For Natera (MEX:NTRA), the current Beginning Cash Position is MXN19,406 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Natera (MEX:NTRA) Overvalued in 2026?
Based on GuruFocus' analysis, Natera stock appears to be overvalued.
The current stock price of MXN4,600.00 is trading 28.2% above its estimated GF Value™ of MXN3,587.26.
GuruFocus considers Natera to be Modestly Overvalued.
Key valuation signals for MEX:NTRA:
Beginning Cash Position: MXN19,406 Mil
GF Value™: MXN3,587.26 vs. price of MXN4,600.00 (28.2% above fair value)
No single metric tells the full story. See the MEX:NTRA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Natera Inc is a diagnostic and research company with proprietary molecular and bioinformatics technology. The company's key product offerings include its Panorama Non-Invasive Prenatal Test (NIPT) which screens for chromosomal abnormalities of a fetus as well as in twin pregnancies, typically with a blood draw from the mother, Horizon Carrier Screening (HCS) to determine carrier status for a large number of severe genetic diseases that could be passed on to the carrier's children, Signatera molecular residual disease (MRD) test, which detects circulating tumor DNA in patients previously diagnosed with cancer to assess molecular residual disease and monitor for recurrence; and Prospera, to assess organ transplant rejection.
60GF Score
Get the complete analysis for MEX:NTRA
Beginning Cash Position is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MEX:NTRA has been successfully added to your 
